Clinical Trials Logo

Clinical Trial Summary

Double-blind, placebo-controlled, First-in-Human, single ascending-dose study. Approximately 40 healthy adult male subjects will be given a single capsule of MYMD1 to determine its safety, how well it is tolerated, how the body acts on the experimental drug, and how the experimental drug acts on the body. This will be based on blood and urine sample analysis and other physical measurements.


Clinical Trial Description

A single-center, double-blind, placebo-controlled, first-in-human, single ascending-dose study to evaluate the safety, tolerability, and pharmacokinetics of single oral dose capsules of MYMD1 in healthy male adult subjects. Each subject will participate in the study for approximately 7 weeks, including a Screening period of up to 30 days, a confinement period of 4 days, and a follow-up period of approximately 2 weeks. In each cohort, 8 subjects will be administered a single dose of either MYMD1 (N=6 in each cohort) or Placebo (N=2 in each cohort), under fasted conditions, and each subject will participate in only 1 of the 5 cohorts during the study. Anticipated dosing levels will be 5mg (Cohort 1), 10mg (Cohort 2), 15mg (Cohort 3), 20mg (Cohort 4), and 25mg (Cohort 5). Sentinel dosing will be used to initiate each cohort, and the first 2 subjects will be randomized 1:1 to receive either MYMD1 or Placebo. The remaining subjects will be dosed 5:1 to receive either MYMD1 or Placebo, respectively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04349761
Study type Interventional
Source MyMD Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 1
Start date June 11, 2019
Completion date December 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT05158985 - Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis N/A
Recruiting NCT06336876 - Perceived Coping, Meaning, and Joy at Work N/A
Recruiting NCT04905095 - CSAPG Early Warning Score N/A
Completed NCT04438356 - M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness N/A
Recruiting NCT06216912 - Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
Recruiting NCT05675930 - A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant Phase 2
Terminated NCT04659122 - A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia Phase 1
Completed NCT04029662 - Reducing Pain Intensity During Spinal Needle Insertion: Valsalva Maneuver vs. Control Technique N/A